HomeNews & MediaPress ReleasesPhilogen Announces Exercise of Options Within the License Agreement With AbbVie in the Field of Immuno-InflammationPress ReleasePublishedFebruary 28, 2018Philogen Announces Exercise of Options Within the License Agreement With AbbVie in the Field of Immuno-InflammationPRESS RELEASE, FEBRUARY 28TH 2018
